270 Participants Needed

mHealth for Sexually Transmitted Infections

MB
Overseen ByMeleah Boyle, MPH
Age: < 65
Sex: Any
Trial Phase: Academic
Sponsor: Children's National Research Institute
Must be taking: Antibiotics
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the mHealth Intervention treatment for sexually transmitted infections?

Research shows that mobile health (mHealth) interventions, like those using mobile phones, can improve sexual health outcomes by increasing STI testing and reducing risky behaviors, such as alcohol use, in young people. These interventions have been effective in promoting sexual health education and behavior change, which are crucial for preventing STIs.12345

Is mHealth for sexually transmitted infections safe for humans?

The research on mHealth interventions for sexually transmitted infections primarily focuses on their effectiveness in improving sexual health knowledge and behavior. There is no specific mention of safety concerns, suggesting that these digital interventions are generally considered safe for human use.36789

How is the mHealth Intervention treatment for sexually transmitted infections different from other treatments?

The mHealth Intervention is unique because it uses mobile phone technology to deliver educational content and promote safe sexual practices, making it more accessible and engaging, especially for young people. Unlike traditional treatments that focus on medication, this approach emphasizes prevention and behavior change through digital means.123610

What is the purpose of this trial?

We will conduct a randomized trial to compare differences in sexually transmitted infection (STI) treatment adherence between patients receiving text messages versus those receiving usual care (e.g. no text messages). We hypothesize that STI treatment adherence will be 20% higher among patients randomized to receipt of two-way text messaging services.

Research Team

MG

Monika Goyal, MD

Principal Investigator

Children's National Research Institute

Eligibility Criteria

This trial is for adolescent patients who have tested positive for gonorrhea, chlamydia, or pelvic inflammatory disease in the Emergency Department and are prescribed outpatient antibiotics.

Inclusion Criteria

I am a teenager treated for an STD with antibiotics after an ER visit.

Exclusion Criteria

Patients will be excluded if they are unable to understand English
Patients will be excluded if they are critically ill
Patients will be excluded if they have cognitive impairment
See 1 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive STI treatment with adherence monitored through text messages or usual care

3 weeks
1 visit (in-person), ongoing text message interactions

Follow-up

Participants are monitored for STI treatment adherence and receipt after treatment

3 weeks

Treatment Details

Interventions

  • mHealth Intervention
Trial Overview The study is testing if sending text messages to these patients can help them follow their STI treatment better compared to those who just get the usual care without texts.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: mHealthExperimental Treatment1 Intervention
Adolescents enrolled in this arm will receive treatment-related text messages.
Group II: Usual careActive Control1 Intervention
Adolescents in this arm will receive usual care.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Children's National Research Institute

Lead Sponsor

Trials
227
Recruited
258,000+

Findings from Research

Mobile health (m-health) interventions have shown a positive impact on sexual health outcomes in adults with chronic diseases, based on a systematic review of nine studies published between 2009 and 2019.
Most interventions were delivered through websites and focused on therapy, self-help, and consultation, particularly for patients with prostate and breast cancer, indicating the need for user-centered design and integration with smartphone apps for enhanced effectiveness.
Mobile health applications for improving the sexual health outcomes among adults with chronic diseases: A systematic review.Karim, H., Choobineh, H., Kheradbin, N., et al.[2022]
Mobile technology interventions, particularly SMS reminders, can significantly improve the uptake of sexual health services and STI testing, as shown in two of the ten randomized trials reviewed.
Despite some positive outcomes, no trials demonstrated a significant increase in condom use, highlighting the need for higher quality studies with standardized measures to better assess the impact of mobile interventions on safer sexual behaviors.
A systematic review of randomised control trials of sexual health interventions delivered by mobile technologies.Burns, K., Keating, P., Free, C.[2022]
Mobile phone-based interventions have the potential to be effective tools for preventing sexually transmitted infections (STIs) and HIV, as they can provide education and promote behavior change among users.
This systematic review will analyze randomized controlled trials to assess the effectiveness of these mobile interventions, ensuring a comprehensive evaluation of their impact on sexual health behaviors.
Effectiveness of digital interventions based on mobile phones for the prevention of sexually transmitted infections: A systematic review protocol.Duarte, G., Vanegas, J., Bravo, G., et al.[2022]

References

Mobile health applications for improving the sexual health outcomes among adults with chronic diseases: A systematic review. [2022]
A systematic review of randomised control trials of sexual health interventions delivered by mobile technologies. [2022]
Effectiveness of digital interventions based on mobile phones for the prevention of sexually transmitted infections: A systematic review protocol. [2022]
Love My Body: Pilot Study to Understand Reproductive Health Vulnerabilities in Adolescent Girls. [2020]
Short message service (SMS) interventions for the prevention and treatment of sexually transmitted infections: a systematic review protocol. [2021]
Development of a Mobile Phone App to Promote Safe Sex Practice Among Youth in Stockholm, Sweden: Qualitative Study. [2020]
The Men's Safer Sex (MenSS) trial: protocol for a pilot randomised controlled trial of an interactive digital intervention to increase condom use in men. [2022]
A systematic review of eHealth modes in preventing sexually transmitted infections. [2023]
Redeveloping a Digital Sexual Health Intervention for Adolescents to Allow for Broader Dissemination: Implications for HIV and STD Prevention. [2021]
Mobile health interventions for HIV/STI prevention among youth in low- and middle-income countries (LMICs): a systematic review of studies reporting implementation outcomes. [2021]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of ServiceยทPrivacy PolicyยทCookiesยทSecurity